Antioxidants enhance the recovery of three cycles of bleomycin, etoposide, and cisplatin-induced testicular dysfunction, pituitary-testicular axis, and fertility in rats

Fertility and Sterility

Volumn 100, Issue 4, 2013, Pages

  Kilarkaje, Narayana ^a   Mousa, Alyaa M ^a   Al Bader, Maie M ^a   Khan, Khalid M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Anticancer drugs; male infertility; pituitary testicular axis; sex hormones

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BLEOMYCIN; CISPLATIN; CYCLINE; ETOPOSIDE; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; SELENIUM; TESTOSTERONE; TRANSFERRIN; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; FERTILITY; GERM CELL; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HYPOPHYSIS TESTIS SYSTEM; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFERTILITY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPERMATID; SPERMATOCYTE; SPERMATOGONIUM; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; TESTIS DISEASE; TESTIS WEIGHT; WESTERN BLOTTING;

ANTICANCER DRUGS; MALE INFERTILITY; PITUITARY-TESTICULAR AXIS; SEX HORMONES;

ALPHA-TOCOPHEROL; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; ASCORBIC ACID; ATROPHY; BLEOMYCIN; BLOTTING, WESTERN; CISPLATIN; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETOPOSIDE; FEMALE; FERTILITY; HORMONES; IMMUNOHISTOCHEMISTRY; MALE; PITUITARY GLAND; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SELENIUM; SPERM COUNT; SPERM MOTILITY; SPERMATOGENESIS; TESTICULAR DISEASES; TESTIS; TIME FACTORS; TRANSFERRIN; ZINC;

EID: 84884908553     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.06.019     Document Type: Article

References (48)

1. K. Kawai, and H. Akaza Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer Cancer Sci 101 2010 22 28
2. B. Hayes-Lattin, and C.R. Nichols Testicular cancer: a prototypic tumor of young adults Semin Onco 36 2009 432 438
3. M. Viatori Testicular cancer Semin Oncol Nurs 28 2012 180 189
4. R.A. Huddart, A. Norman, C. Moynihan, A. Horwich, C. Parker, and E. Nicholls Fertility, gonadal and sexual function in survivors of testicular cancer Br J Cancer 93 2005 200 207 (Pubitemid 41133206)
5. M. Brydøy, S.D. Fosså, O. Klepp, R.M. Bremnes, E.A. Wist, T. Wentzel-Larsen Norwegian Urology Cancer Group III Study Group Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy Eur Urol 58 2010 134 140
6. P. Albers, R. Siener, S. Krege, H.U. Schmelz, K.P. Dieckmann, A. Heidenreich German Testicular Cancer Study Group Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group J Clin Oncol 26 2008 2966 2972
7. S. Culine, A. Kramar, C. Théodore, L. Geoffrois, C. Chevreau, and P. Biron Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP J Clin Oncol 26 2008 421 427 (Pubitemid 351171694)
8. D.R. Feldman, G.J. Bosl, J. Sheinfeld, and R.J. Motzer Medical treatment of advanced testicular cancer JAMA 299 2008 672 684 (Pubitemid 351252727)
9. A. Bamias, G. Aravantinos, I. Kastriotis, G. Alivizatos, I. Anastasiou, and C. Christodoulou Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group Urol Oncol 29 2011 189 193
10. F. Calabrò, P. Albers, C. Bokemeyer, C. Martin, L.H. Einhorn, and A. Horwich The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature Eur Urol 61 2012 1212 1221
11. S.J. Howell, and S.M. Shalet Spermatogenesis after cancer treatment: Damage and recovery J Natl Cancer Monogr Inst 34 2005 12 17
12. S.J. Howell, and S.M. Shalet Testicular function following chemotherapy Hum Reprod Update 7 2001 363 369 (Pubitemid 32655321)
13. K. Jahnukainen, J. Ehmcke, M. Hou, and S. Schlatt Testicular function and fertility preservation in male cancer patients Best Pract Res Clin Endocrinol Metab 25 2011 287 302
14. A.M. Bieber, L. Marcon, B.F. Hales, and B. Robaire Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, permatozoa, and fertility J Androl 27 2006 189 200
15. L. Marcon, B.F. Hales, and B. Robaire Reversibility of the effects of subchronic exposure to the cancer chemotherapeutics bleomycin, etoposide, and cisplatin on spermatogenesis, fertility, and progeny outcome in the male rat J Androl 29 2008 408 417 (Pubitemid 351929926)
16. L. Marcon, X. Zhang, B.F. Hales, B. Robaire, and M.C. Nagano Effects of chemotherapeutic agents for testicular cancer on rat spermatogonial stem/progenitor cells J Androl 32 2011 432 443
17. G. Delbes, B.F. Hales, and B. Robaire Effects of the chemotherapy cocktail used to treat testicular cancer on sperm chromatin integrity J Androl 28 2007 241 249 (Pubitemid 46423905)
18. D. Chan, G. Delbès, M. Landry, B. Robaire, and J.M. Trasler Epigenetic alterations in sperm DNA associated with testicular cancer treatment Toxicol Sci 125 2012 532 543
19. K. Narayana, M. Al-Bader, A. Mousa, and K.M. Khan Molecular effects of chemotherapeutic drugs and their modulation by antioxidants in the testis Eur J Pharmacol 674 2012 207 216
20. S.J. Howell, and S.M. Shalet Effect of cancer therapy on pituitary-testicular axis Int J Androl 25 2002 269 276
21. W. Brennemann, B. Stoffel-Wagner, A. Helmers, J. Mezger, N. Jäger, and D. Klingmüller Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer J Urol 158 1997 844 850
22. S.J. Howell, J.A. Radford, W.D. Ryder, and S.M. Shalet Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency J Clin Oncol 17 1999 1493 1498 (Pubitemid 29220857)
23. G. Pühse, A. Secker, S. Kemper, L. Hertle, and S. Kliesch Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment Int J Androl 34 2011 e351 e357
24. C. Wyns, M. Curaba, B. Vanabelle, A. Van Langendonckt, and J. Donnez Options for fertility preservation in prepubertal boys Hum Rep Update 16 2010 312 328
25. K.M. Brown, and J.R. Arthur Selenium, selenoproteins and human health: a review Public Health Nutr 4 2001 593 599 (Pubitemid 32524579)
26. A. Agarwal, S.A. Prabhakaran, and T.M. Said Prevention of oxidative stress injury to sperm J Androl 26 2005 654 660 (Pubitemid 41476621)
27. E.G. Brandt, M. Hellgren, T. Brinck, T. Bergman, and O. Edholm Molecular dynamics study of zinc binding to cysteines in a peptide mimic of the alcohol dehydrogenase structural zinc site Phys Chem Chem Phys 11 2009 975 983
28. M.G. Traber, and J.F. Stevens Vitamins C and E: beneficial effects from a mechanistic perspective Free Radic Biol Med 51 2011 1000 1013
29. H.D. Mistry, F. Broughton Pipkin, C.W. Redman, and L. Poston Selenium in reproductive health Am J Obstet Gynecol 206 2012 21 30
30. G. Delbès, D. Chan, P. Pakarinen, J.M. Trasler, B.F. Hales, and B. Robaire Impact of the chemotherapy cocktail used to treat testicular cancer on the gene expression profile of germ cells from male Brown-Norway rats Biol Reprod 80 2009 320 327
31. K. Narayana, N. Prashanthi, A. Nayanatara, H.H. Kumar, K. Abhilash, and K.L. Bairy Effects of methyl parathion (o, o-dimethyl o-4-nitrophenyl phosphorothioate) on rat sperm morphology and sperm count, but not fertility, are associated with decreased ascorbic acid level in the testis Mutat Res 588 2005 28 34 (Pubitemid 41627849)
32. K. Narayana, S. Verghese, and S.S. Jacob L-Ascorbic acid partially protects two cycles of cisplatin chemotherapy-induced testis damage and oligo-astheno-teratospermia in a mouse model Exp Toxicol Pathol 61 2009 553 563
33. K. Narayana, U.J.A. d'Souza, P. Narayan, and G. Kumar The antiviral drug ribavirin reversibly affects the reproductive parameters in the male Wistar rat Folia Morphol 64 2005 65 71 (Pubitemid 40867663)
34. H.E. Chemes, and V.Y. Rawe The making of abnormal spermatozoa: cellular and molecular mechanisms underlying pathological spermiogenesis Cell Tissue Res 341 2010 349 357
35. K. Narayana, U.J.A. d'Souza, and K.P.S. Rac Ribavirin induced sperm shape abnormalities in Wistar rat Mutation Res 513 2002 193 196 (Pubitemid 33096338)
36. J. Maselli, B.F. Hales, P. Chan, and B. Robaire Exposure to bleomycin, etoposide, and cis-platinum alters rat sperm chromatin integrity and sperm head protein profile Biol Reprod 166 2012 1 10
37. E.A. Salem, N.A. Salem, A.M. Maarouf, E.C. Serefoglu, and W.J. Hellstrom Selenium and lycopene attenuate cisplatin-induced testicular toxicity associated with oxidative stress in Wistar rats Urology 79 2012 1184.e1 1184.e6 10.1016/j.urology.2011.12.006
38. E.A. Ahmed, H.M. Omar, SKh Elghaffar, S.M. Ragb, and A.Y. Nasser The antioxidant activity of vitamin C, DPPD and L-cysteine against cisplatin-induced testicular oxidative damage in rats Food Chem Toxicol 49 2011 1115 1121
39. Y.O. Ilbey, E. Ozbek, A. Simsek, A. Otunctemur, M. Cekmen, and A. Somay Potential chemoprotective effect of melatonin in cyclophosphamide- and cisplatin-induced testicular damage in rats Fertil Steril 92 2009 1124 1132
40. G. Türk, A. Ateşşahin, M. Sönmez, A.C. Ceribaşi, and A. Yüce Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid Fertil Steril 89 2008 1474 1481 (Pubitemid 351680100)
41. J. Lackner, G. Schatzl, A. Koller, P. Mazal, T. Waldhoer, and M. Marberger Treatment of testicular cancer: influence on pituitary-gonadal axis and sexual function Urology 66 2005 402 406 (Pubitemid 41138106)
42. P. Wiechno, T. Demkow, K. Kubiak, M. Sadowska, and J. Kamińska The quality of life and hormonal disturbances in testicular cancer survivors in cisplatin era Eur Urol 52 2007 1448 1454
43. M.M. García, A. Acquier, G. Suarez, N.V. Gomez, A. Gorostizaga, and C.F. Mendez Cisplatin inhibits testosterone synthesis by a mechanism that includes the action of reactive oxygen species (ROS) at the level of P450scc Chem Biol Interact 199 2012 185 191
44. P.M. Petersen, A. Giwercman, N.E. Skakkebaek, and M. Rørth Gonadal function in men with testicular cancer Semin Oncol 25 1998 224 233
45. R.A. Hess, and M. Nakai Histopathology of the male reproductive system induced by the fungicide benomyl Histol Histopathol 15 2000 207 224 (Pubitemid 30044305)
46. G.-L. Moldovan, B. Pfander, and S. Jentsch PCNA, the maestro of the replication fork Cell 129 2007 665 679 (Pubitemid 46802385)
47. S.N. Naryzhny Proliferating cell nuclear antigen: a proteomics view Cell Mol Life Sci 65 2008 3789 3808
48. L. Marcon, X. Zhang, B.F. Hales, M.C. Nagano, and B. Robaire Development of a short-term fluorescence-based assay to assess the toxicity of anticancer drugs on rat stem/progenitor spermatogonia in vitro Biol Reprod 83 2010 228 237